---
phase: 01-baseline-measurement
plan: 02
subsystem: documentation
tags: [baseline, metrics, evaluation, research, presidio, adversarial]

# Dependency graph
requires:
  - phase: 01-01
    provides: F2 score metric and confusion matrix export
  - phase: 01-03
    provides: Adversarial dataset for edge case evaluation
provides:
  - Comprehensive baseline metrics document with timestamped snapshot
  - Per-entity performance analysis for all 8 PHI types
  - Adversarial vs standard dataset comparison
  - Critical gap identification for Phase 4 priorities
affects: [02-threshold-calibration, 03-deny-list-refinement, 04-pattern-improvements, 05-validation]

# Tech tracking
tech-stack:
  added: []
  patterns:
    - "Baseline documentation before system improvements"
    - "Adversarial dataset comparison for edge case analysis"

key-files:
  created:
    - .planning/phases/01-baseline-measurement/BASELINE_METRICS.md
  modified: []

key-decisions:
  - "MEAS-02 (human-annotated gold standard) deferred to Phase 5 for IRB coordination"
  - "Adversarial dataset provides edge case coverage in lieu of real transcripts for Phase 1"
  - "Baseline documents current state (77.9% recall) as defensible research evidence"

patterns-established:
  - "Pattern 1: Capture baseline metrics before any improvements for research validation"
  - "Pattern 2: Document both standard and adversarial dataset performance for edge case analysis"

# Metrics
duration: 7min
completed: 2026-01-23
---

# Phase 01 Plan 02: Baseline Metrics Documentation

**Comprehensive baseline performance snapshot before any system improvements**

## Performance

- **Duration:** 7 min
- **Started:** 2026-01-23T13:22:03Z
- **Completed:** 2026-01-23T13:29:47Z
- **Tasks:** 2
- **Files created:** 1

## Accomplishments
- Captured baseline metrics from 500-sample standard dataset (77.9% recall, 66.3% precision, 75.3% F2)
- Documented per-entity performance for all 8 PHI types with TP/FN/FP counts
- Compared standard vs adversarial dataset performance (100 adversarial samples)
- Identified critical gaps: PEDIATRIC_AGE (37% recall), ROOM (34% recall), LOCATION (19% recall)
- Catalogued 13 failing tests out of 36 total test suite
- Documented known limitations including MEAS-02 deferral to Phase 5
- Created improvement roadmap for Phases 2-5 based on baseline weaknesses

## Task Commits

Each task was committed atomically:

1. **Task 1: Run evaluation and capture metrics** - Data collection only (no commit)
2. **Task 2: Create BASELINE_METRICS.md document** - `3235197` (docs)

## Files Created/Modified
- `.planning/phases/01-baseline-measurement/BASELINE_METRICS.md` (343 lines) - Comprehensive baseline documentation with standard and adversarial metrics

## Decisions Made

**1. MEAS-02 deferral to Phase 5**
- Rationale: Human-annotated gold standard requires IRB coordination (out of scope for Phase 1 baseline measurement)
- Phase 1 uses synthetic datasets (standard + adversarial) as gold standard
- Real transcript annotation is validation-phase work, not baseline-phase work
- This deferral is intentional and documented in "Known Limitations" section

**2. Adversarial dataset as edge case coverage**
- Rationale: 100-sample adversarial dataset compensates for synthetic data limitations
- Provides targeted edge case testing (6 categories: speech artifacts, diverse names, boundary edges, transcription errors, compound patterns, age edges)
- Reveals critical weaknesses: PEDIATRIC_AGE drops to 25% recall, ROOM drops to 19% recall
- Informs Phase 4 priority ordering

**3. Baseline captures current state for research evidence**
- Rationale: Research project requires defensible "before" snapshot
- 77.9% recall baseline will be compared against post-improvement metrics
- All subsequent improvements measured against this timestamp (2026-01-23 13:22:03 EST)
- Document provides evidence for research poster and QI project documentation

## Deviations from Plan

None - plan executed exactly as written.

## Issues Encountered

None - evaluation ran smoothly, all data captured successfully.

## Baseline Key Findings

### Overall Performance
- **Recall**: 77.9% (target: >95%) - **17.1% below target**
- **Precision**: 66.3% (target: >70%) - **3.7% below target**
- **F2 Score**: 75.3% (primary metric for recall emphasis)
- **Safety Status**: ❌ FAILED - 369 PHI leaks detected

### Critical Weaknesses
1. **LOCATION**: 19.4% recall (104 false negatives) - hospital names, addresses, city names missed
2. **PEDIATRIC_AGE**: 36.6% recall (104 false negatives) - abbreviations (yo, mo), DOL format, verbose forms missed
3. **ROOM**: 34.4% recall (59 false negatives) - unit prefixes (bed, bay, isolette), multi-part formats, standalone digits missed

### Adversarial Dataset Insights
- PEDIATRIC_AGE drops to 25% recall on edge cases (abbreviations completely missed)
- ROOM drops to 19% recall on edge cases (standalone digits and unit prefixes missed)
- PHONE_NUMBER improves to 87% recall (better than standard 74%)
- LOCATION shows 100% recall but only 1 entity in dataset (insufficient coverage)

### Test Suite Status
- 23 passing tests (basic detection works)
- 13 failing tests (edge cases expose systematic weaknesses)
- Primary failures: bulk detection tests for PERSON, PHONE_NUMBER, MRN, LOCATION

## Next Phase Readiness

### Phase 2: Threshold Calibration
- Baseline thresholds documented: detection=0.35, validation=0.7
- Confusion matrix data available for precision-recall curve generation
- Expected impact: +5-10% precision, +2-5% recall

### Phase 3: Deny List Refinement
- Current deny list case sensitivity inconsistencies documented
- Medical abbreviations identified for expansion (NC, RA, OR, IV, PO, etc.)
- Expected impact: +3-5% precision (fewer false positives)

### Phase 4: Pattern Improvements
**Priority ordering from baseline analysis:**
1. PEDIATRIC_AGE patterns (+40-50% recall expected) - highest impact
2. ROOM patterns (+40-50% recall expected) - second highest impact
3. PHONE_NUMBER patterns (+10-15% recall expected) - moderate impact
4. LOCATION patterns (+30-40% recall expected) - moderate impact

### Phase 5: Validation on Real Transcripts
- IRB coordination required for real transcript access
- Expert clinical annotation of PHI needed
- Baseline provides comparison point for real-world performance

---
*Phase: 01-baseline-measurement*
*Completed: 2026-01-23*
